HUNTSVILLE, AL, July 29, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (SER), a clinical-stage biotechnology company developing its proprietary POZ Platform â„¢ drug optimization technology, today ...
Apptium technology accelerates TD SYNNEX’s multi-year development of the company’s StreamOne platform, enhances its cloud commerce platform and simplifies complexity. The transaction strengthens TD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results